Option B+ for the prevention of mother-to-child transmission of HIV infection in developing countries: a review of published cost-effectiveness analyses

The costs and benefits of Option B+ for the prevention of mother-to-child transmission of HIV

(2014) Chaitra Gopalappa et al.   AIDS

Universal Public Finance of Tuberculosis Treatment in India: An Extended Cost-Effectiveness Analysis

(2014) Stéphane Verguet et al.   HEALTH ECONOMICS

Health Outcomes and Cost Impact of the New WHO 2013 Guidelines on Prevention of Mother-to-Child Transmission of HIV in Zambia

(2014) Naoko Ishikawa et al.   PLoS One

Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement

(2013) Don Husereau et al.   BMC Medicine

Cost-Effectiveness Analysis of Option B+ for HIV Prevention and Treatment of Mothers and Children in Malawi

(2013) Olufunke Fasawe et al.   PLoS One

Non-nucleoside reverse transcriptase inhibitors: a review on pharmacokinetics, pharmacodynamics, safety and tolerability

(2013) Iris Usach et al.   Journal of the International AIDS Society

Antiretroviral Drug Regimens to Prevent Mother-To-Child Transmission of HIV: A Review of Scientific, Program, and Policy Advances for Sub-Saharan Africa

(2013) Benjamin H. Chi et al.   Current HIV/AIDS Reports

Evaluating the cost-effectiveness of combination antiretroviral therapy for the prevention of mother-to-child transmission of HIV in Uganda

(2012) Andreas Kuznik et al.   BULLETIN OF THE WORLD HEALTH ORGANIZATION

Cost-effectiveness of World Health Organization 2010 Guidelines for Prevention of Mother-to-Child HIV Transmission in Zimbabwe

(2012) Andrea L. Ciaranello et al.   CLINICAL INFECTIOUS DISEASES

Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models

(2012) Nigel Rollins et al.   SEXUALLY TRANSMITTED INFECTIONS

Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach

(2011) Erik J Schouten et al.   LANCET

Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial

(2011)   LANCET INFECTIOUS DISEASES

Cost Effectiveness in Low- and Middle-Income Countries

(2009) Samuel D. Shillcutt et al.   PHARMACOECONOMICS